Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,194
datasets available to search
ShareScore release 0.9.0
Dataset results
2,194 results for “Diffusers”
Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00294632. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02142049. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma
ClinicalTrials.gov study NCT00566228. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2
ClinicalTrials.gov study NCT01724021. IPD Sharing: Not stated. Countries: 32. Publications: 2.
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01649856. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03589469. IPD Sharing: NO. Countries: 4. Publications: 7.
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lym
ClinicalTrials.gov study NCT02951156. IPD Sharing: YES. Countries: 8. Publications: 1.
Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial
ClinicalTrials.gov study NCT01285557. IPD Sharing: Not stated. Countries: 20. Publications: 1.
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01092182. IPD Sharing: YES. Countries: 1. Publications: 2.
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00118209. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
ClinicalTrials.gov study NCT02161406. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02926833. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
ClinicalTrials.gov study NCT01287741. IPD Sharing: Not stated. Countries: 29. Publications: 14.
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT00869999. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
ClinicalTrials.gov study NCT03274076. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
ClinicalTrials.gov study NCT04440592. IPD Sharing: UNDECIDED. Countries: 8. Publications: 1.
Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02285062. IPD Sharing: Not stated. Countries: 21. Publications: 3.
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03681535. IPD Sharing: NO. Countries: 6. Publications: 1.
A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
ClinicalTrials.gov study NCT00036569. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients
ClinicalTrials.gov study NCT01994850. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.